MedAvail to Report Fourth Quarter and Full Year 2022 Financial Results on March 30

Rhea-AI Summary

MedAvail Holdings, Inc. (Nasdaq: MDVL) will release its financial results for Q4 and full-year 2022 on March 30, 2023, after market close. A conference call/webcast is scheduled for the same day at 4:30 PM ET. This innovative pharmacy technology company is known for its MedCenter robotic dispensing platform, aiming to enhance drug adherence and health outcomes for patients. Investors can tune into the call at 1-877-704-4453 (domestic) or 1-201-389-0920 (international) with Conference ID 13736400. The live webcast will also be available on the company’s website, with an archived replay accessible post-event.

Positive

• Scheduled financial results announcement for Q4 and full-year 2022, indicating transparency with investors.
• Webcast of the investor conference call allows widespread access for updates.

Negative

• None.

Management to host investor conference call and webcast at 4:30pm ET on that day

PHOENIX, March 16, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today announced that the Company will announce financial results for the fourth quarter and full-year ended December 31, 2022 on Thursday, March 30, after the close of the financial markets. MedAvail management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Call and webcast details:
Thursday, March 30, 2023 @ 4:30pm ET
Investor dial-in: 1-877-704-4453 (domestic) or 1-201-389-0920 (international)
Conference ID: 13736400
To access the Call me™ feature, which avoids having to wait for an operator, click here.

The live audio webcast can be accessed by registering online on the “Investor Relations” section of MedAvail’s website at: https://investors.medavail.com. The webcast will be archived and available for replay after the event.

About MedAvail
MedAvail Holdings, Inc. (NASDAQ: MDVL) is a pharmacy technology company, providing turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter. MedAvail helps patients to optimize drug adherence, resulting in better health outcomes. Learn more at www.medavail.com.

Contacts: 
Investor Relations 
Steven Halper/Caroline Paul
Managing Directors, LifeSci Advisors 
ir@medavail.com

SOURCE MedAvail Holdings, Inc.

FAQ

When will MedAvail announce its Q4 2022 financial results?

MedAvail will announce its Q4 2022 financial results on March 30, 2023, after market close.

What time is the MedAvail investor conference call scheduled?

The investor conference call is scheduled for March 30, 2023, at 4:30 PM ET.

How can I access the MedAvail earnings call?

You can access the MedAvail earnings call by dialing 1-877-704-4453 (domestic) or 1-201-389-0920 (international) with Conference ID 13736400.

Where can I find the MedAvail earnings call webcast?

The earnings call webcast can be found on the Investor Relations section of MedAvail’s website.

What technology does MedAvail use to improve pharmacy services?

MedAvail uses its proprietary robotic dispensing platform, the MedCenter, to enhance pharmacy services and optimize drug adherence.